Viking Therapeutics, Inc.
VKTX
Classement en actions
#4567
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.
Prix de l'action
$26.38
Capitalisation boursière
$3.35B
Changement (1 jour)
-1.23%
Changement (1 an)
-20.01%
Pays
US
Échange Viking Therapeutics, Inc. (VKTX)
Catégorie
Healthcare
Historique des divisions d’actions pour Viking Therapeutics, Inc. (VKTX)
L’action Viking Therapeutics, Inc. (symbole : VKTX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action VKTX achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions VKTX.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action VKTX achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions VKTX.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| Pas assez de données pour les dates fournies. | |||
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
